Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 1998, p. 2440-2442, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Microbicidal Activity of a New Silver-Containing
Polymer, SPI-ARGENT II
Günter
Kampf,1,*
Beate
Dietze,1
Christian
Große-Siestrup,2
Constanze
Wendt,1 and
Heike
Martiny1
Institut für Hygiene, Umweltmedizin und
Arbeitsmedizin, Freie Universität Berlin, 12203 Berlin,1 and
Tierexperimentelle
Einrichtung, Humboldt Universität, Virchow-Klinikum, 13353 Berlin,2 Germany
Received 31 December 1997/Returned for modification 31 March
1998/Accepted 16 June 1998
 |
ABSTRACT |
The survival of three bacterial species and Candida
albicans was studied on SPI-ARGENT II. The immediate recovery
from silver-impregnated polymer and control polymer (1 cm2)
was ~106 to 107 microorganisms. After
incubation (37°C) and neutralization of silver with horse serum
(5%), surviving organisms were recovered. The survival of the
microorganisms on the polymer was not found to be influenced by the
silver implantation.
 |
TEXT |
Catheter-related infections are
common in hospitalized patients in the United States and Europe
(2). The case fatality rate for catheter-related bacteremia
(CRB) has been estimated to be 10 to 20% (5). Bacteria may
colonize the medical device and migrate along it inside the lumen or
outside at the surface, resulting in CRB (14). To reduce
CRB, the primary approach involved replacing the device at certain
intervals, but frequent replacement leads to an increase in medical
costs. In addition, repetitive attempts of cannulation required for
device replacement can enhance the risk of bacterial colonization and
subsequent infection. Antiseptic treatment of indwelling or
percutaneous devices, such as urinary catheters and central venous
catheters, has been developed to reduce the incidence of CRB and to
reduce medical costs when replacement of a device becomes necessary
less often. Various antiseptics, such as silver (3, 4, 19),
benzalkonium chloride (21), iodine (8), Irgasan
(11-13), and chlorhexidine (3, 15), and
antibiotics, such as dicloxacillin (20), teicoplanin
(7), minocycline with rifampin (17), and
mupirocin (6), have been tested for this purpose. Silver
sulfadiazine and chlorhexidine in combination with silver sulfadiazine
are among the most common agents (3). There are several
methods to impregnate a device with silver in order to achieve a
gradual release (18, 19). Spire Services Technology Systems
(SSTS [Milan, Italy]) has developed an ion implantation technique to
silver-coat the device polymer as an "actively sterile" surface
(SPI-ARGENT II). It is a vacuum process in which ions are generated
from a source, accelerated, and injected into the subsurface region.
According to the company, the silver-impregnated polymer is highly
bactericidal to Staphylococcus aureus, Pseudomonas
aeruginosa, Escherichia coli, and Candida albicans. We studied the microbicidal activity of this new polymer in vitro in comparison to that of the untreated polymer.
The microorganisms included S. aureus ATCC 6538, P. aeruginosa ATCC 15442, E. coli ATCC 11229, and C. albicans ATCC 10231. Bacterial strains were passaged three times
on tryptose agar plates (product no. CM 233; Oxoid, Basingstoke,
England) supplemented with 5% sheep blood, and C. albicans
was passaged three times on Sabouraud-glucose agar (product no. CM 41;
Oxoid) before experiments were carried out. The device polymer with and
without silver ion implantation was purchased from SSTS. A piece of
~15 by 15 cm was available for all experiments.
Silver was neutralized with 5% horse serum (product no. SR 35; Oxoid)
(22). The efficacy of horse serum to neutralize silver was
shown in three parallel experiments before the survival experiments were carried out. The end point was survival or no survival of the
microorganisms in the presence of silver. The experiment was controlled
for survival in distilled water. Bacteria were incubated in
silver-containing distilled water at 37°C for 48 h, and C. albicans organisms were incubated at 30°C for 72 h.
S. aureus, P. aeruginosa, E. coli, and
C. albicans were not able to survive silver at a
concentration of 0.0125 ppm (survival controls without silver were
positive). In the presence of horse serum (5%), however, S. aureus, P. aeruginosa, and E. coli were able
to survive silver at a concentration of 0.8 ppm, and C. albicans was able to survive even at a silver concentration of 1.6 ppm.
Pieces 1 cm2 in size were cut from
nonantiseptic-impregnated and silver-impregnated polymer with sterile
scissors. They were inoculated either with five colonies of each
microorganism by using a sterile swab (dry inoculum) or with 50 µl of
a suspension with sterile saline (liquid inoculum). The inoculated
pieces were incubated in a humid chamber at 37°C. Recovery of the
organisms was carried out immediately after the inoculation (time 0)
and after 1 h, 24 h, and 7 days. Pieces were placed into
glass tubes containing tryptic soy broth and horse serum (5%) to
neutralize the silver. A serial dilution was performed. Fractions of
100 µl were distributed from appropriate dilutions on tryptic soy agar or Sabouraud agar with a spiralometer (Whitley automatic spiral-plater; Don Whitley Scientific, Ltd., Shipley, England). The
remaining broth was filtered with cellulose nitrate membranes (pore
size, 0.2 µm). Tryptic soy agar plates were incubated at 37°C for
48 h, and Sabouraud agar plates were incubated at 30°C for
72 h. The number of colonies was determined, and the total number
of surviving organisms was calculated (recovery rate). Six parallel
experiments were carried out with all four microorganisms (dry
inoculum) and with P. aeruginosa and S. aureus
(liquid inoculum) at each reaction time for both the ion-implanted
polymer and the control polymer.
The log10 number of organisms recovered from each type of
polymer was calculated for each of six parallel experiments (one colony
was assumed when zero colonies were detected after filtration). Data
are presented as means ± standard deviations for each organism and reaction time. The Mann-Whitney U test was used to compare the
number of recovered organisms between the two polymers at a specific
time (1). A P value of <0.05 was regarded as
significant.
Significant differences between the number of organisms on both
polymers were only found for S. aureus after 24 h (dry
inoculum, P = 0.037 [Table
1]; liquid inoculum, P = 0.004 [Table 2]) and C. albicans after 24 h (dry inoculum, P = 0.004 [Table 1]). E. coli and P. aeruginosa did not
yield significant differences between the polymers at any reaction time
(Tables 1 and 2).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Number of CFU of four microorganisms (dry inoculum) on a
polymer without and with silver after various exposure times
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Number of CFU of two microorganisms (liquid inoculum) on
a polymer without and with silver after various exposure times
|
|
Various methods are available to impregnate device polymer with silver.
SSTS has developed an ion implantation technique and claims that the
polymer (SPI-ARGENT II) is microbicidal to S. aureus,
E. coli, P. aeruginosa, and C. albicans. We studied the survival of the same microorganisms at
incubation times of 1 h, 24 h, and 7 days. No significant
difference in the number of surviving organisms was found between the
polymer with and without silver at any time for any microorganism,
except for C. albicans after 24 h (dry inoculum, colony
count on silver-impregnated polymer significantly higher) and S. aureus after 24 h (dry inoculum, colony count on
silver-impregnated polymer significantly higher; liquid inoculum,
colony count on the control polymer significantly higher). This finding
is in contrast to the information offered by the manufacturer of this
new polymer, who claims that the surface produces 100% killing of
bacteria in both short-term tests (30 to 45 min) and long-term studies
(42 days) by the shake flask method.
Various methods are available to study the microbicidal activity of
silver ions in a polymer. The manufacturer was able to demonstrate the
antimicrobial effectiveness by the shake flask method as follows.
Treated and control samples are directly inoculated with an organism
suspended in a buffered solution. Samples are agitated continuously for
1 h, serially diluted, and counted by the plate count method.
According to the manufacturer, the surface is bactericidal on contact
and minimally leaching. That is why we have chosen a method which
allows assessment of microbicidal activity on contact by closely
resembling the bacterial or fungal colonization of a device. In our
method, bacteria and fungi are inoculated onto the silver ion-implanted
polymer surface, and their survival is studied in comparison to that
with the nontreated polymer. According to our results, we cannot
exclude that it is the polymer itself and not the ion implantation
which may have a microbicidal effect, if there is any effect at all.
Lower inocula may yield very different results and allow for
differentiation. Due to the limited availability of the polymer,
further experiments with a lower inoculum were not possible.
Neutralization of an antiseptic is very important in in vitro testing,
because residual activity of the antiseptic may result in false
high-reduction factors. We have used horse serum (5%) to neutralize
residual silver. In preliminary experiments, we were able to
demonstrate that horse serum can neutralize silver at a concentration
of up to 0.8 ppm. Dilution of microorganisms in tryptic soy broth
instead of horse serum in the presence of silver yielded the same
result. It is therefore possible that the horse serum effect is not
neutralization but an effect on the bacteria. The manufacturer of
SPI-ARGENT II does not provide any information about whether residual
silver has been neutralized in the shake flask method or which
neutralizing agents have been used. This is a possible explanation for
the discrepancy between our results and the information provided by the
manufacturer. Other investigators have used a combination of 5% Tween,
2% lecithin, 0.6% sodium oleate, 0.5% sodium thiosulfate, 0.1%
proteose peptone, and 0.1% tryptone to neutralize silver sulfadiazine
and chlorhexidine (3). Whatever combination of neutralizing
agents is used, effective neutralization of residual antiseptics is a
condition for in vitro testing of antiseptic materials (19).
It will also play a crucial role in the microbiology laboratory when
antiseptic-coated catheters are to be investigated for bacterial or
fungal colonization (23).
In addition to the antimicrobial effect of a polymer, the adhesive
effect of the polymer surface for bacteria and fungi is of importance
(9). SPI-ARGENT II silicone rubber is minimally adhesive
according to the manufacturer, with a critical surface tension of 27 dynes per cm (control silicone rubber, 14 dynes per cm). Material with
a surface tension of between 20 and 30 dynes per cm is regarded as
naturally thromboresistant and bacteriostatic. The survival of E. coli was surprisingly poor on both polymers in comparison to that
of the other microorganisms. It is possible that this finding is due to
a serum bactericidal effect. Repeating the experiments with another
method for neutralization could help to explain this finding.
We did not investigate the adhesive effect of the SPI-ARGENT
II, but we noticed that liquid application of the microorganisms did
not result in complete wetting of the surface, indicating the presence
of some surface tension on both polymers. Further experiments will be
necessary to study the adhesive effect of the polymer. Antiseptic
treatment of device material should not only have an in vitro
microbicidal effect but should also significantly reduce the incidence
of catheter-associated nosocomial infections. Antimicrobial coating of
central venous lines has been shown to decrease the rate of
catheter-associated infections (10). Coating of the outer
surface may not be sufficient, because the internal lumen becomes more
important with time of catheterization as a risk factor for CRB
(16). The impact of an antiseptic-treated device on the
clinical outcome will decide its use in the future.
Our data provide evidence that implantation of silver ion into the
polymer (SPI-ARGENT II) does not influence the survival of various
microorganisms compared with that with the control polymer. Its value
for clinical use appears to be doubtful.
 |
ACKNOWLEDGMENTS |
We thank Gabriele Rose and Petra Falkenberg for all technical
assistance with carrying out the experiments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Hygiene, Umweltmedizin und Arbeitsmedezin, Freie
Universität Berlin, 12203 Berlin, Germany. Phone: 49 30 8445 3680. Fax: 49 30 8445 3682.
 |
REFERENCES |
| 1.
|
Altman, D. G.
1991.
Practical statistics for medical research, 1st ed.
Chapman & Hall, London, United Kingdom.
|
| 2.
|
Anonymous.
1996.
National nosocomial infections surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996.
Am. J. Infect. Control
24:380-388[Medline].
|
| 3.
|
Bach, A.,
H. Böhrer,
J. Motsch,
E. Martin,
H. K. Geiss, and H. G. Sonntag.
1994.
Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers.
J. Antimicrob. Chemother.
33:969-978[Abstract/Free Full Text].
|
| 4.
|
Böswald, M.,
M. Girisch,
J. Greil,
T. Spies,
K. Stehr,
T. Krall, and J.-P. Guggenbichler.
1995.
Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: a new perspective in prevention of polymer-associated foreign-body-infections.
Zentralbl. Bakteriol.
283:187-200[Medline].
|
| 5.
|
Cobb, D. K.,
K. B. High,
R. G. Sawyer,
C. A. Sable,
R. B. Adams,
T. L. Lindley,
T. L. Pruett,
K. J. Schwenzer, and B. M. Farr.
1992.
A controlled trial of scheduled catheter replacement of central venous and pulmonary-artery catheters.
N. Engl. J. Med.
327:1062-1068[Abstract].
|
| 6.
|
Hill, R. L. R.,
A. P. Fisher,
R. J. Ware,
S. Wilson, and M. W. Casewell.
1990.
Mupirocin for the reduction of colonization of internal jugular cannulae a randomised controlled trial.
J. Hosp. Infect.
15:311-321[Medline].
|
| 7.
|
Jansen, B.,
S. Jansen,
G. Peters, and G. Pulverer.
1992.
In vitro efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin to prevent bacterial colonisation.
J. Hosp. Infect.
22:93-107[Medline].
|
| 8.
|
Jansen, B.,
K. G. Kristinsson,
S. Jansen,
G. Peters, and G. Pulverer.
1992.
In vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonisation.
J. Antimicrob. Chemother.
30:135-139[Abstract/Free Full Text].
|
| 9.
|
Jansen, B., and G. Peters.
1991.
Modern strategies in the prevention of polymer-associated infections.
J. Hosp. Infect.
19:83-88[Medline].
|
| 10.
|
Kamal, G. D.,
M. A. Pfaller,
L. E. Rempe, and P. J. Jebson.
1991.
Reduced intravascular catheter infection by antibiotic bonding.
JAMA
265:2364-2368[Abstract/Free Full Text].
|
| 11.
|
Kingston, D.,
E. D. C. Birnie,
J. Martin,
P. C. Pearce,
S. Manek, and C. M. Quinn.
1992.
Experimental pathology of intravenous polyurethane cannulae containing disinfectant.
J. Hosp. Infect.
20:257-270[Medline].
|
| 12.
|
Kingston, D., and I. D. Hill.
1990.
Elution of disinfectant from polyurethane cannula tubing.
J. Hosp. Infect.
16:271-280[Medline].
|
| 13.
|
Kingston, D., and D. V. Seal.
1986.
Self-disinfecting plastics for intravenous catheters and prosthetic inserts.
J. Hyg. Camb.
96:185-198[Medline].
|
| 14.
|
Liñares, J.,
A. Sitges-Serra,
J. Garau,
J. L. Pérez, and R. Martin.
1985.
Pathogenesis of catheter sepsis: a prospective study with quantitative cultures of catheter hub and segments.
J. Clin. Microbiol.
21:357-360[Abstract/Free Full Text].
|
| 15.
|
Maki, D. G.,
M. Ringer, and C. J. Alvarado.
1991.
Prospective randomised trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
Lancet
338:339-343[Medline].
|
| 16.
|
Raad, I.,
W. Costerton,
U. Sabharwal,
M. Sacilowski,
E. Anaissie, and G. P. Bodey.
1993.
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.
J. Infect. Dis.
168:400-407[Medline].
|
| 17.
|
Raad, I.,
R. Darouiche,
R. Hachem,
M. Mansouri, and G. P. Bodey.
1996.
The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
J. Infect. Dis.
173:418-424[Medline].
|
| 18.
|
Raad, I.,
R. Hachem,
A. Zermeno,
L. Clifton Stephens, and G. P. Bodey.
1996.
Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device.
J. Infect. Dis.
173:495-498[Medline].
|
| 19.
|
Schmitt, S. K.,
C. Knapp,
G. S. Hall,
D. L. Longworth,
J. T. McMahon, and J. A. Washington.
1996.
Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.
J. Clin. Microbiol.
34:508-511[Abstract].
|
| 20.
|
Sheretz, R. J.,
D. M. Forman, and D. D. Solomon.
1989.
Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.
Antimicrob. Agents Chemother.
33:1174-1178[Abstract/Free Full Text].
|
| 21.
|
Tebbs, S. E., and T. S. J. Elliott.
1993.
A novel antimicrobial central venous catheter impregnated with benzalkonium chloride.
J. Antimicrob. Chemother.
31:261-271[Abstract/Free Full Text].
|
| 22.
|
Wallhäuser, K. H.
1988.
Praxis der Sterilisation-Desinfektion-Konservierung-Keimidentifizierung-Betriebshygiene, 4th ed.
Thieme, Stuttgart, Germany.
|
| 23.
|
Widmer, A. F.
1997.
Intravenous-related infections, p. 771-805.
In
R. P. Wenzel (ed.), Prevention and control of nosocomial infections, 3rd ed. Williams & Wilkins, Baltimore, Md.
|
Antimicrobial Agents and Chemotherapy, September 1998, p. 2440-2442, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schierholz, J. M., Beuth, J., Pulverer, G., Konig;, D.-P., Scharlack;, R. S., Kampf, G., Dietze, B., Wendt, C., Martiny, H., Gro{beta}e-Siestrup, C.
(1999). Silver-Containing Polymers. Antimicrob. Agents Chemother.
43: 2819-2821
[Full Text]